Showing results (371-380 of 989) with videos related to

Sort By:
Pageof 99
Blood|August 15, 2002
Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493)Joseph A Sparano, Edie Weller, Tipu Nazeer, et al.
Cancer Medicine|August 27, 2020
Investigating the impact of open label design on patient-reported outcome results in prostate cancer randomized controlled trialsGuillaume Mouillet, Fabio Efficace, Antoine Thiery-Vuillemin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 3, 1999
Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical centerJ A Sparano, K Anand, J Desai, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019Fabio Efficace, Johannes M Giesinger, David Cella, et al.
British Journal of Cancer|January 1, 1997
Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significanceC Yiangou, J J Gomm, R C Coope, et al.
Breast Cancer Research and Treatment|February 19, 2013
Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic diseaseJanice Diaz, Lesley Stead, Nella Shapiro, et al.
Cancer Research|August 1, 1993
Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancerJ A Sparano, S Wadler, L Liebes, et al.
Journal of Clinical Medicine|August 28, 2025
Mechanical Circulatory Support in Paraganglioma Induced Cardiogenic Shock and Intestinal Ischemia: Lessons from a Complex Case and Narrative ReviewAlessio Giordano, Letizia Canu, Manuela Mastronardi, et al.
Acta Ophthalmologica|May 12, 2010
Morphological and functional correlations in riboflavin UV A corneal collagen cross-linking for keratoconusCosimo Mazzotta, Tomaso Caporossi, Rosario Denaro, et al.
Oncotarget|January 10, 2018
The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistanceChristopher D Suarez, Junmin Wu, Sunil S Badve, et al.
Pageof 99